Ulisse Biomed Statistics

Total Valuation

Ulisse Biomed has a market cap or net worth of EUR 21.19 million. The enterprise value is 18.90 million.

Market Cap	21.19M
Enterprise Value	18.90M

Important Dates

The next estimated earnings date is Friday, September 27, 2024.

Earnings Date	Sep 27, 2024
Ex-Dividend Date	n/a

Share Statistics

Ulisse Biomed has 21.81 million shares outstanding.

Shares Outstanding	21.81M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	316.72
PB Ratio	0.77
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.94
EV / Sales	285.52
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.35, with a Debt / Equity ratio of 1.82.

Current Ratio	2.35
Quick Ratio	1.69
Debt / Equity	1.82
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-34,880.29

Financial Efficiency

Return on equity (ROE) is -28.81% and return on invested capital (ROIC) is -17.93%.

Return on Equity (ROE)	-28.81%
Return on Assets (ROA)	-15.69%
Return on Capital (ROIC)	-17.93%
Revenue Per Employee	6,621
Profits Per Employee	-479,685
Employee Count	10
Asset Turnover	0.00
Inventory Turnover	1.53

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -47.25% in the last 52 weeks. The beta is 0.59, so Ulisse Biomed's price volatility has been lower than the market average.

Beta (5Y)	0.59
52-Week Price Change	-47.25%
50-Day Moving Average	1.00
200-Day Moving Average	1.35
Relative Strength Index (RSI)	44.17
Average Volume (20 Days)	7,000

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Ulisse Biomed had revenue of EUR 66,208 and -4.80 million in losses. Loss per share was -0.22.

Revenue	66,208
Gross Profit	-1.55M
Operating Income	-4.85M
Pretax Income	-4.80M
Net Income	-4.80M
EBITDA	-4.72M
EBIT	-4.85M
Loss Per Share	-0.22

Balance Sheet

The company has 2.79 million in cash and 496,779 in debt, giving a net cash position of 2.29 million or 0.11 per share.

Cash & Cash Equivalents	2.79M
Total Debt	496,779
Net Cash	2.29M
Net Cash Per Share	0.11
Equity (Book Value)	27.35M
Book Value Per Share	1.27
Working Capital	4.07M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	-7,322.92%
Pretax Margin	-7,245.12%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Ulisse Biomed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-22.88%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a